Creative Planning’s Aratana Therapeutics, Inc. PETX Stock Holding History

Creative Planning’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-20,687	Closed	-$127K	–	2127
2018 Q4	$127K	Buy	+20,687	New	+$126K	﹤0.01%	1592
2016 Q4	–	Sell	-170	Closed	-$2K	–	4980
2016 Q3	$2K	Hold	170	–	–	﹤0.01%	4302
2016 Q2	$1K	Buy	+170	New	+$1.09K	﹤0.01%	4273
2015 Q1	–	Sell	-1,500	Closed	-$27K	–	4495
2014 Q4	$27K	Hold	1,500	–	–	﹤0.01%	2454
2014 Q3	$15K	Hold	1,500	–	–	﹤0.01%	2722
2014 Q2	$23K	Sell	1,500 -50,769	-97%	-$719K	﹤0.01%	2413
2014 Q1	$970K	Buy	+52,269	New	+$1.05M	0.01%	379

Other funds holding PETX

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Creative Planning's PETX Position: Q1 2019 in Review

Creative Planning sold out of Aratana Therapeutics, Inc. (PETX) in Q1 2019, closing a stake of 20,687 shares — an estimated $127K sold.

Creative Planning first reported a position in PETX in Q1 2014 and held it in 7 quarters. The position peaked at $970K in Q1 2014. 104 funds tracked by Wall St. Rank hold PETX as of Q1 2019.

Creative Planning reported no remaining Aratana Therapeutics, Inc. position as of Q1 2019 after selling out during the quarter.
Creative Planning sold 20,687 Aratana Therapeutics, Inc. shares in Q1 2019, an estimated $127K.
Creative Planning first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Creative Planning's Aratana Therapeutics, Inc. position peaked at $970K in Q1 2014.
104 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q1 2019.

Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.